SMTL ID : 7wue.2 (1 other biounit)

Crystal structure of SARS-CoV-2 Receptor Binding Domain in complex with the monoclonal antibody m31A7

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.20 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.1: 4 residues within 4Å: Chain A: F.6, G.7, F.10, N.11 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-FUC.2: 8 residues within 4Å: Chain B: V.117, Y.118, N.119, Y.120 Chain C: K.56, Y.75, W.76, E.81 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:K.56, C:K.56

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Huang, H.Y. et al., Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models. Sci Transl Med (2022)

Release Date

2022-03-16

Peptides

Spike protein S1: A
m31A7 Fab HEAVY CHAIN: B
m31A7 Fab LIGHT CHAIN: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
E

C
F

Spike protein S1

m31A7 Fab HEAVY CHAIN

m31A7 Fab LIGHT CHAIN

Related Entries With Identical Sequence